Just to share 100% anecdotal experience being a Korean, having lived/worked in Korea on and off for past 20 years.
I am Korean native but an American. In Korea, men and women use "botox" products routinely. In Korea, botox injection cost is very affordable (Chinese origin is cheapest, maybe $100/injection that lasts 2-3 mo.; Korean origin maybe $120/injection 3-4 mo.). It has become a routine part of people's aesthetics routine, and very widely used.
This has been a phenomenon for 10 years and thus a routine, and aesthetics shops are very competitive in pricing.
For us, if there is a botox product that truly lasts 2x longer (from 3-4 mo. to 6 mo), I think there would be a large adoption, even at a slight premium (I have no idea what the RVNC pricing might look like in the USA or international).
Problem with Allergan competitors today is that all of those products do not truly offer differentiation, that I am aware of. So, some people in Korea go w/ Chinese product due to being cheapest (young, ordinary students, etc); next would be Korean local product as they are reliable and affordable (my wife when we lived there); and more affluent people (Kang-nam millionaires or wanna-be's) might go for Allergan brand (or whatever is latest name brand) just b/c they can afford it.
I have been an investor for many years w/ RVNC. I am a firm believer of their success IF they can get the FDA nod in Sept. And unlike most FDA approved drugs, I think RVNC lead product will gain fast and wide acceptance (20%-25% w/in 3-4 years).
So, I get the naysayers in the past, but I like RVNC chances.
By the way, I don't see any poss. scenario that RVNC goes alone down the road. Larger Pharma will be in a better position to use scale and resources to accelerate adoption. RVNC has to get bought out w/in 24 mo.
my 5 cents worth. (well lately w/ my bio land performance - maybe my NEGATIVE 25 cents worth).
Buyout should be at least 4-5B for RVNC BOD to approve, I think.
